NCT03355001

Brief Summary

The Monosyn® Quick non-interventional study (NIS) has been designed to implement an action within the framework of a proactive post-market surveillance system. The aim of this NIS is to collect systematically and proactively different clinical parameters regarding safety, effectiveness and performance of Monosyn® Quick suture material under the daily clinical practice when used as intended.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

January 3, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2019

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2019

Completed
Last Updated

January 11, 2022

Status Verified

December 1, 2021

Enrollment Period

1.7 years

First QC Date

October 26, 2017

Last Update Submit

December 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complication

    Descriptive Analysis of the Frequency of tissue reaction or inflammation, wound infection, seroma, fistula, abscess formation, hematoma, suture removal or re-suturing at different time points

    at follow-up visit depending on routine clinical practice (approx. 1-3 months postoperatively)

Secondary Outcomes (7)

  • Complications

    until day of discharge (approximately 1 week)

  • Dehiscence

    until day of discharge (approximately 1 week) and at follow-up visit depending on routine clinical practice (approx. 1-3 months postoperatively)

  • Patient and Observer Scar Assessment Scale (POSAS)

    at day of discharge (approximately 1 week) and at follow-up visit depending on routine clinical practice (approx. 1-3 months postoperatively)

  • Cosmetic outcome

    at day of discharge (approximately 1 week) and at follow-up visit depending on routine clinical practice (approx. 1-3 months postoperatively)

  • Pain

    at day of discharge (approximately 1 week) and at follow-up visit depending on routine clinical practice (approx. 1-3 months postoperatively)

  • +2 more secondary outcomes

Study Arms (3)

Skin Closure

Monosyn® Quick will be used for skin closure for the adaptation of soft tissue and mucous membranes, when wound support over a period of 7 days is considered adequate.

Device: Monosyn® Quick

Urology

Monosyn® Quick will be used in urology for the adaptation of soft tissue and mucous membranes, when wound support over a period of 7 days is considered adequate.

Device: Monosyn® Quick

Gynecology

Monosyn® Quick will be used in gynecology for the adaptation of soft tissue and mucous membranes, when wound support over a period of 7 days is considered adequate.

Device: Monosyn® Quick

Interventions

* Mucosal sutures in the facial and oral * Dermal sutures, particularly in pediatrics * Episiotomy * Circumcision

GynecologySkin ClosureUrology

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pediatric and adult patients undergoing mucosal wound or skin closure using Monosyn® Quick as suture material or women undergoing an episiotomy or pediatric patients undergoing an urological intervention as a circumcision or phimosis or hypospadias

You may qualify if:

  • Pediatric and adult patients undergoing mucosal wound or skin closure using Monosyn® Quick as suture material or women undergoing an episiotomy or pediatric patients undergoing an urological intervention such as a circumcision or phimosis or hypospadias etc.
  • Written informed regarding the data collection for the Post Market Clinical Follow-Up (PMCF)

You may not qualify if:

  • \- None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Leopoldina-Krankenhaus GmbH

Schweinfurt, Bavaria, 97422, Germany

Location

Benedictus Krankenhaus Tutzing GmbH & Co.

Tutzing, Bavaria, 82327, Germany

Location

Klinikum der Johann-Wolfgang-Goethe Universität, Department for Pediatric Surgery and Pediatric Urology

Frankfurt am Main, Hesse, 60590, Germany

Location

Related Publications (2)

  • Baumann P, Gumpinger F. Prospective, Observational Study to Assess a New Quick Absorbable Monofilament Suture for Skin Closure in Adults. Journal of Surgery 2021; 9(2):63.

    RESULT
  • Baumann P, Weigel M. Episiotomy Closure After Vaginal Delivery-A Prospective, Single Centre Study Assessing a Novel Fast-Absorbable, Monofilament Suture in Daily Practice. Journal of Surgery 2021; 9(3):121.

    RESULT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2017

First Posted

November 28, 2017

Study Start

January 3, 2018

Primary Completion

September 18, 2019

Study Completion

September 21, 2019

Last Updated

January 11, 2022

Record last verified: 2021-12

Locations